Hyperglycaemia, microangiopathy, diabetes and dementia risk

I Bourdel-Marchasson1, A Mouries, C Helmer

  • 1CHU of Bordeaux, Department of Gerontology, Bordeaux, France. isabelle.bourdel-marchasson@chu-bordeaux.fr

Diabetes & Metabolism
|January 8, 2011
PubMed

Insights

Brain microangiopathy, common in aging, hypertension, and diabetes, affects cognitive function. Further research is needed to monitor progression, identify reversible stages, and develop preventive strategies for diabetic patients.

Area of Science:

  • Neurology
  • Gerontology
  • Endocrinology

Background:

  • Brain microangiopathy prevalence and severity increase with age, hypertension, and diabetes.
  • Magnetic resonance imaging offers anatomical insights, but clinical and neuropsychological assessments are crucial for evaluating white matter function.
  • Clinical manifestations include subcortical cognitive alterations, with ongoing debate regarding dementia risk.

Purpose of the Study:

  • To address critical questions regarding brain microangiopathy.
  • To explore monitoring methods, reversibility, and preventive actions for aging individuals with diabetes.
  • To determine optimal care strategies for slowing cognitive decline in diabetic patients with cognitive impairment.

Main Methods:

  • Review of existing literature on brain microangiopathy.
  • Analysis of clinical examination and neuropsychological testing data.
  • Correlation of chronic hyperglycemia with microvascular complications.

Main Results:

  • Brain microangiopathy is linked to chronic hyperglycemia, sharing mechanisms with retinopathy.
  • Current methods for monitoring progression and identifying reversible stages are insufficient.
  • Data on the direct link between microangiopathy and dementia risk remain controversial.

Conclusions:

  • Urgent need for validated methods to monitor brain microangiopathy progression.
  • Investigating potential reversible stages is critical for therapeutic interventions.
  • Developing targeted preventive and care strategies for diabetic patients is essential to mitigate cognitive decline.

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.